Clinical research at Mount Vernon Cancer Centre that could drastically improve the survival chances of women with cervical cancer in the future is well underway.
Clinical research at Mount Vernon Cancer Centre that could drastically improve the survival chances of women with cervical cancer in the future is well underway. The EMPIRIC study, which is supported by Paul Strickland Scanner Centre, aims to use our advanced MRI techniques in combination with other tests to predict a patient’s response to treatment and whether they might be at greater risk of seeing their cancer return.
According to Senior Clinical Research Felllow Dr Mohammed Abdul-Latif, the study is progressing very well.
He said: “We have successfully recruited 6 patients of the 40 we need for the study and are on track to complete within the next 2-3 years. The quality of the MRI scans produced by Paul Strickland Scanner Centre are excellent. We are honoured by the willingness of patients who have so far consented to the EMPIRIC study. Their enthusiasm to join the study reflects how important research is to our patients. Thanks to their contribution, we are collecting data vital to demonstrating the value of MRI in improving the treatment of cervical cancer. We have also shown that incorporating multiple, complicated MRI scans into cervical cancer radiotherapy is feasible and this opens the door to wider use of MRI in this context.”